| [1] | Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, 2022; 183, 109119. doi: 10.1016/j.diabres.2021.109119 |
| [2] | Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev, 2019; 40, 1109−51. doi: 10.1210/er.2018-00126 |
| [3] | Szymczak-Pajor I, Śliwińska A. Analysis of association between vitamin D deficiency and insulin resistance. Nutrients, 2019; 11, 794. doi: 10.3390/nu11040794 |
| [4] | Fleet JC. The role of vitamin D in the endocrinology controlling calcium homeostasis. Mol Cell Endocrinol, 2017; 453, 36−45. doi: 10.1016/j.mce.2017.04.008 |
| [5] | Trexler AJ, Taraska JW. Regulation of insulin exocytosis by calcium-dependent protein kinase C in beta cells. Cell Calcium, 2017; 67, 1−10. doi: 10.1016/j.ceca.2017.07.008 |
| [6] | Dunlop TW, Väisänen S, Frank C, et al. The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha, 25-dihydroxyvitamin D3 and its nuclear receptor. J Mol Biol, 2005; 349, 248−60. doi: 10.1016/j.jmb.2005.03.060 |
| [7] | Fernandez GJ, Ramírez-Mejía JM, Urcuqui-Inchima S. Vitamin D boosts immune response of macrophages through a regulatory network of microRNAs and mRNAs. J Nutr Biochem, 2022; 109, 109105. doi: 10.1016/j.jnutbio.2022.109105 |
| [8] | Vasdeki D, Tsamos G, Dimakakos E, et al. Vitamin D supplementation: shedding light on the role of the sunshine vitamin in the prevention and management of Type 2 diabetes and its complications. Nutrients, 2024; 16, 3651. doi: 10.3390/nu16213651 |
| [9] | Pittas AG, Dawson-Hughes B, Sheehan P, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med, 2019; 381, 520−30. doi: 10.1056/NEJMoa1900906 |
| [10] | Zheng JS, Luan JA, Sofianopoulou E, et al. The association between circulating 25-hydroxyvitamin D metabolites and type 2 diabetes in European populations: a meta-analysis and Mendelian randomisation analysis. PLoS Med, 2020; 17, e1003394. doi: 10.1371/journal.pmed.1003394 |
| [11] | Ye Z, Sharp SJ, Burgess S, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol, 2015; 3, 35−42. doi: 10.1016/S2213-8587(14)70184-6 |
| [12] | Boucher BJ. Why do so many trials of vitamin D supplementation fail? Endocr Connect, 2020; 9, R195-206. |
| [13] | Cranney A, Horsley T, O’Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep), 2007; 1-235. |
| [14] | Afraie M, Bahrami P, Kohnepoushi P, et al. The effect of vitamin D supplementation on glycemic control and cardiovascular risk factors in type 2 diabetes: an updated systematic review and meta-analysis of clinical trials. J Diabetes Res, 2024; 2024, 9960656. doi: 10.1155/2024/9960656 |
| [15] | Lei XX, Zhou Q, Wang YM, et al. Serum and supplemental vitamin D levels and insulin resistance in T2DM populations: a meta-analysis and systematic review. Sci Rep, 2023; 13, 12343. doi: 10.1038/s41598-023-39469-9 |
| [16] | Krul-Poel YHM, ter Wee MM, Lips P, et al. MANAGEMENT OF ENDOCRINE DISEASE: the effect of vitamin D supplementation on glycaemic control in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Eur J Endocrinol, 2017; 176, R1−14. doi: 10.1530/EJE-16-0391 |
| [17] | George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med, 2012; 29, e142−50. |
| [18] | Leucht S, Chaimani A, Cipriani AS, et al. Network meta-analyses should be the highest level of evidence in treatment guidelines. Eur Arch Psychiatry Clin Neurosci, 2016; 266, 477−80. doi: 10.1007/s00406-016-0715-4 |
| [19] | Parums DV. Editorial: review articles, systematic reviews, meta-analysis, and the updated preferred reporting items for systematic reviews and meta-analyses (PRISMA) 2020 guidelines. Med Sci Monit, 2021; 27, e934475. |
| [20] | Cumpston M, Li TJ, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst Rev, 2019; 10, ED000142. |
| [21] | Wan X, Wang WQ, Liu JM, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol, 2014; 14, 135. doi: 10.1186/1471-2288-14-135 |
| [22] | Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ, 2019; 366, l4898. |
| [23] | McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods, 2021; 12, 55−61. doi: 10.1002/jrsm.1411 |
| [24] | White IR. NETWORK: stata module to perform network meta-analysis. Boston College Department of Economics. 2017. |
| [25] | Higgins JPT, Jackson D, Barrett JK, et al. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies. Res Synth Methods, 2012; 3, 98−110. doi: 10.1002/jrsm.1044 |
| [26] | Dias S, Welton NJ, Caldwell DM, et al. Checking consistency in mixed treatment comparison meta-analysis. Stat Med, 2010; 29, 932−44. doi: 10.1002/sim.3767 |
| [27] | Mbuagbaw L, Rochwerg B, Jaeschke R, et al. Approaches to interpreting and choosing the best treatments in network meta-analyses. Syst Rev, 2017; 6, 79. doi: 10.1186/s13643-017-0473-z |
| [28] | Yu-Kang T. Node-splitting generalized linear mixed models for evaluation of inconsistency in network meta-analysis. Value Health, 2016; 19, 957−63. doi: 10.1016/j.jval.2016.07.005 |
| [29] | Borenstein M. How to understand and report heterogeneity in a meta-analysis: the difference between I-squared and prediction intervals. Integr Med Res, 2023; 12, 101014. doi: 10.1016/j.imr.2023.101014 |
| [30] | Borenstein M. In a meta-analysis, the I-squared statistic does not tell us how much the effect size varies. J Clin Epidemiol, 2022; 152, 281−4. doi: 10.1016/j.jclinepi.2022.10.003 |
| [31] | Borenstein M, Higgins JPT, Hedges LV, et al. Basics of meta-analysis: I2 is not an absolute measure of heterogeneity. Res Synth Methods, 2017; 8, 5−18. doi: 10.1002/jrsm.1230 |
| [32] | Chaimani A, Higgins JPT, Mavridis D, et al. Graphical tools for network meta-analysis in STATA. PLoS One, 2013; 8, e76654. doi: 10.1371/journal.pone.0076654 |
| [33] | Shantah Al_Sadkhan AS, Ali DS, Alluaibi SS. The correlation between the effect of vitamin D3 and both glycated hemoglobin and fasting glucose levels in Iraqi females in the province of Maysan who have uncontrolled type 2 diabetes. HIV Nurs, 2022; 22, 248‐53. |
| [34] | Nikooyeh B, Neyestani TR, Farvid M, et al. Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr, 2011; 93, 764−71. doi: 10.3945/ajcn.110.007336 |
| [35] | The TIDE Trial Investigators. Design, history and results of the Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) randomised controlled trial. Diabetologia, 2012; 55, 36−45. doi: 10.1007/s00125-011-2357-4 |
| [36] | Barale M, Giaccherino RR, Ghigo E, et al. Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study. J Endocrinol Invest, 2021; 44, 791−802. doi: 10.1007/s40618-020-01373-8 |
| [37] | Breslavsky A, Frand J, Matas Z, et al. Effect of high doses of vitamin D on arterial properties, adiponectin, leptin and glucose homeostasis in type 2 diabetic patients. Clin Nutr, 2013; 32, 970‐5. |
| [38] | Ryu OH, Chung W, Lee S, et al. The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes. Korean J Intern Med, 2014; 29, 620−9. doi: 10.3904/kjim.2014.29.5.620 |
| [39] | Aguayo-Ruiz JI, García-Cobián TA, Pascoe-González S, et al. Effect of supplementation with vitamins D3 and K2 on undercarboxylated osteocalcin and insulin serum levels in patients with type 2 diabetes mellitus: a randomized, double-blind, clinical trial. Diabetol Metab Syndr, 2020; 12, 73. doi: 10.1186/s13098-020-00580-w |
| [40] | Lo MC, Abushamat L, Mramba LK. Effect of treating vitamin D deficiency in uncontrolled type 2 diabetes: a randomized, placebo-controlled study. Am J Ther, 2019; 26, e441‐51. |
| [41] | Agarwal C, Marwah S, Kulshrestha B, et al. Effect of vitamin D replacement therapy on glycaemic control in type 2 diabetic mellitus patients. J Clin Diagn Res, 2017; 11, OC40‐3. doi: 10.1111/crj.12544 |
| [42] | Ghavamzadeh S, Mobasseri M, Mahdavi R. The effect of vitamin D supplementation on adiposity, blood glycated hemoglobin, serum leptin and tumor necrosis factor-α in type 2 diabetic patients. Int J Prev Med, 2014; 5, 1091‐8. |
| [43] | Al-Sofiani ME, Jammah A, Racz M, et al. Effect of vitamin D supplementation on glucose control and inflammatory response in type II diabetes: a double blind, randomized clinical trial. Int J Endocrinol Metab, 2015; 13, e22604. |
| [44] | Krul-Poel YHM, Westra S, ten Boekel E, et al. Effect of vitamin D supplementation on glycemic control in patients with type 2 diabetes (SUNNY trial): a randomized placebo-controlled trial. Diabetes Care, 2015; 38, 1420‐6. |
| [45] | El Hajj C, Walrand S, Helou M, et al. Effect of vitamin D supplementation on inflammatory markers in non-obese lebanese patients with type 2 diabetes: a randomized controlled trial. Nutrients, 2020; 12(7), 2033. |
| [46] | Rashidi H, Ghaderian SB, Shirinpour Z, et al. The effect of vitamin D supplementation on insulin resistance and glycemic control in patients with type 2 diabetes. Int J Pharm Technol, 2016; 8(2), 11665‐74. |
| [47] | Mozaffari M, Hajmoradi H, Moravveji A, et al. The effect of vitamin d therapy on glycemic control and biochemical indices in type 2 diabetic patients: a randomized, clinical trial study. Physiol Pharmacol, 2021; 25, 125‐33. |
| [48] | Rajendran P, Varadarajan S, James J, et al. Effectiveness and safety of low dose vitamin D as an adjunct therapy in patients with type 2 diabetes mellitus: a double-blind, randomised, controlled study. J Pharm Negat Results, 2022; 13, 2076‐81. |
| [49] | Kampmann U, Mosekilde L, Juhl C, et al. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial. Metabolism, 2014; 63, 1115‐24. |
| [50] | Imanparast F, Javaheri J, Kamankesh F, et al. The effects of chromium and vitamin D3 co-supplementation on insulin resistance and tumor necrosis factor-alpha in type 2 diabetes: a randomized placebo-controlled trial. Appl Physiol Nutr Metab, 2020; 45, 471‐7. |
| [51] | Sun XM, Yan T, Li ZY, et al. Effects of endurance exercise and vitamin D supplementation on insulin resistance and plasma lipidome in middle-aged adults with type 2 diabetes. Nutrients, 2023; 15, 3027. doi: 10.3390/nu15133027 |
| [52] | Hu ZY, Zhi XY, Li JF, et al. Effects of long-term vitamin D supplementation on metabolic profile in middle-aged and elderly patients with type 2 diabetes. J Steroid Biochem Mol Biol, 2023; 225, 106198. doi: 10.1016/j.jsbmb.2022.106198 |
| [53] | Zarei M, Javanbakht MH, Jafary H, et al. Effects of vitamin D on serum levels and gene expression of enzymes aldose reductase, o-linked n-acetyl glucosamine transferase and glutamine fructose-6-phosphate aminotransferase in patients with type 2 diabetes: a randomized, double blind, placebo controlled clinical trial. Int J Food Prop, 2021; 24, 337−45. doi: 10.1080/10942912.2021.1879131 |
| [54] | Omidian M, Djalali M, Javanbakht MH, et al. Effects of vitamin D supplementation on advanced glycation end products signaling pathway in T2DM patients: a randomized, placebo-controlled, double blind clinical trial. Diabetol Metab Syndr, 2019; 11, 86. doi: 10.1186/s13098-019-0479-x |
| [55] | Omidian M, Mahmoudi M, Abshirini M, et al. Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: randomized placebo-controlled double-blind clinical trial. Diabetes Metab Syndr, 2019; 13, 2375‐80. |
| [56] | Gulseth HL, Wium C, Angel K, et al. Effects of vitamin D supplementation on insulin sensitivity and insulin secretion in subjects with type 2 diabetes and vitamin D deficiency: a randomized controlled trial. Diabetes Care, 2017; 40, 872‐8. |
| [57] | Cojic M, Kocic R, Klisic A, et al. The effects of vitamin D supplementation on metabolic and oxidative stress markers in patients with type 2 diabetes: a 6-month follow up randomized controlled study. Front Endocrinol, 2021; 12, 610893. doi: 10.3389/fendo.2021.610893 |
| [58] | Jafari T, Faghihimani E, Feizi A, et al. Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: a randomised controlled clinical trial. Clin Nutr, 2016; 35, 67‐76. |
| [59] | Khan DM, Jamil A, Randhawa FA, et al. Efficacy of oral vitamin D on glycated haemoglobin (HbA1c) in type 2 diabetics having vitamin D deficiency — a randomized controlled trial. J Pak Med Assoc, 2018; 68, 694−7. |
| [60] | Nasri H, Behradmanesh S, Maghsoudi AR, et al. Efficacy of supplementary vitamin D on improvement of glycemic parameters in patients with type 2 diabetes mellitus; a randomized double blind clinical trial. J Renal Inj Prev, 2014; 3, 31‐4. |
| [61] | Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: a pilot prospective randomized trial. J Diabetes, 2010; 2, 36‐40. |
| [62] | Ryu OH, Lee S, Yu J, et al. A prospective randomized controlled trial of the effects of vitamin D supplementation on long-term glycemic control in type 2 diabetes mellitus of Korea. Endocr J, 2014; 61, 167‐76. |
| [63] | Dalan R, Liew H, Assam PN, et al. A randomised controlled trial evaluating the impact of targeted vitamin D supplementation on endothelial function in type 2 diabetes mellitus: the DIMENSION trial. Diab Vasc Dis Res, 2016; 13, 192‐200. |
| [64] | Elkassaby S, Harrison LC, Mazzitelli N, et al. A randomised controlled trial of high dose vitamin D in recent-onset type 2 diabetes. Diabetes Res Clin Pract, 2014; 106, 576‐82. |
| [65] | Shab-Bidar S, Neyestani TR, Djazayery A, et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med, 2011; 9, 125. doi: 10.1186/1741-7015-9-125 |
| [66] | Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr, 2009; 48, 349‐54. |
| [67] | Anyanwu AC, Fasanmade OA, Coker HAB, et al. Vitamin D supplementation improves insulin resistance in type 2 diabetes subjects in Lagos, Nigeria. Afr J Diabetes Med, 2017; 25, 14‐7. |
| [68] | Sadiya A, Ahmed SM, Carlsson M, et al. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial. Eur J Clin Nutr, 2015; 69, 707‐11. |
| [69] | Angellotti E, D'Alessio D, Dawson-Hughes B, et al. Vitamin D supplementation in patients with type 2 diabetes: the vitamin D for established type 2 diabetes (DDM2) study. J Endocr Soc, 2018; 2, 310‐21. |
| [70] | Thenmozhi P, Sekar R, Bhuvaneswari G, et al. Vitamin D supplementation of glycemic control in type 2 diabetes mellitus patients: a randomized controlled study. Int J Nutr, Pharmacol, Neurol Dis, 2024; 14, 323‐8. |
| [71] | Wenclewska S, Szymczak-Pajor I, Drzewoski J, et al. Vitamin D supplementation reduces both oxidative DNA damage and insulin resistance in the elderly with metabolic disorders. Int J Mol Sci, 2019; 20, 2891. doi: 10.3390/ijms20122891 |
| [72] | Al-Zahrani MK, Elnasieh AM, Alenezi FM, et al. A 3-month oral vitamin D supplementation marginally improves diastolic blood pressure in Saudi patients with type 2 diabetes mellitus. Int J Clin Exp Med, 2014; 7, 5421−8. |
| [73] | Zerwekh JE. Blood biomarkers of vitamin D status. Am J Clin Nutr, 2008; 87, 1087S−91S. doi: 10.1093/ajcn/87.4.1087S |
| [74] | Cashman KD, van den Heuvel EG, Schoemaker RJ, et al. 25-hydroxyvitamin D as a biomarker of vitamin D status and its modeling to inform strategies for prevention of vitamin D deficiency within the population. Adv Nutr, 2017; 8, 947−57. doi: 10.3945/an.117.015578 |
| [75] | Wu WX, Zhou JC, Yang LC. Surveillance and evaluation of vitamin D nutrition and its health impact in Chinese older adults. J Nutr, 2025; 155, 1031−40. doi: 10.1016/j.tjnut.2025.01.030 |
| [76] | Szymczak-Pajor I, Drzewoski J, Śliwińska A. The molecular mechanisms by which vitamin D prevents insulin resistance and associated disorders. Int J Mol Sci, 2020; 21, 6644. doi: 10.3390/ijms21186644 |
| [77] | Mohammadi S, Hajhashemy Z, Saneei P. Serum vitamin D levels in relation to type-2 diabetes and prediabetes in adults: a systematic review and dose-response meta-analysis of epidemiologic studies. Crit Rev Food Sci Nutr, 2022; 62, 8178−98. doi: 10.1080/10408398.2021.1926220 |
| [78] | He LP, Li CP, Liu CW, et al. The regulatory effect of vitamin D on pancreatic beta cell secretion in patients with type 2 diabetes. Curr Med Chem, 2024; 31, 1−10. doi: 10.2174/092986733101230723022504 |
| [79] | Neelankal John A, Jiang FX. An overview of type 2 diabetes and importance of vitamin D3-vitamin D receptor interaction in pancreatic β-cells. J Diabetes Complications, 2018; 32, 429−43. doi: 10.1016/j.jdiacomp.2017.12.002 |
| [80] | Qi JW, Huang B, Wang S, et al. Association between plasma vitamin D2 and type 2 diabetes mellitus. Front Endocrinol, 2022; 13, 897316. doi: 10.3389/fendo.2022.897316 |
| [81] | Yu XF, Lim CED, Chen H. The role of vitamin D in glycaemic control in patients with type 2 diabetes-a pilot D4D trial. Diabetes Obes Metab, 2025; 27, 428−31. doi: 10.1111/dom.16023 |
| [82] | Vijan S, Sussman JB, Yudkin JS, et al. Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med, 2014; 174, 1227−34. doi: 10.1001/jamainternmed.2014.2894 |
| [83] | Lee CJ, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: a systematic review and meta-analysis of intervention studies. J Diabetes Complications, 2017; 31, 1115−26. doi: 10.1016/j.jdiacomp.2017.04.019 |
| [84] | Mirhosseini N, Vatanparast H, Mazidi M, et al. The effect of improved serum 25-hydroxyvitamin D status on glycemic control in diabetic patients: a meta-analysis. J Clin Endocrinol Metab, 2017; 102, 3097−110. doi: 10.1210/jc.2017-01024 |
| [85] | Li YT, Chen J, Man QQ, et al. Dose-response relationship between serum 25(OH)D and the risk of abnormal glycemic status in Chinese older adults. Metabolites, 2024; 14, 579. doi: 10.3390/metabo14110579 |
| [86] | Musazadeh V, Kavyani Z, Mirhosseini N, et al. Effect of vitamin D supplementation on type 2 diabetes biomarkers: an umbrella of interventional meta-analyses. Diabetol Metab Syndr, 2023; 15, 76. doi: 10.1186/s13098-023-01010-3 |
| [87] | Chen W, Liu LL, Hu F. Efficacy of vitamin D supplementation on glycaemic control in type 2 diabetes: an updated systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab, 2024; 26, 5713−26. doi: 10.1111/dom.15941 |
| [88] | Kazemi A, Ryul Shim S, Jamali N, et al. Comparison of nutritional supplements for glycemic control in type 2 diabetes: a systematic review and network meta-analysis of randomized trials. Diabetes Res Clin Pract, 2022; 191, 110037. doi: 10.1016/j.diabres.2022.110037 |
| [89] | Zhang YJ, Xue Y, Zhang DD, et al. Effect of vitamin D supplementation on glycemic control in prediabetes: a meta-analysis. Nutrients, 2021; 13, 4464. doi: 10.3390/nu13124464 |
| [90] | Zittermann A, Trummer C, Theiler-Schwetz V, et al. Long-term supplementation with 3200 to 4000 IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials. Eur J Nutr, 2023; 62, 1833−44. doi: 10.1007/s00394-023-03124-w |
| [91] | Jorde R, Sollid ST, Svartberg J, et al. Vitamin D 20, 000 IU per week for five years does not prevent progression from prediabetes to diabetes. J Clin Endocrinol Metab, 2016; 101, 1647−55. doi: 10.1210/jc.2015-4013 |
| [92] | Gallagher JC, Rosen CJ. Vitamin D: 100 years of discoveries, yet controversy continues. Lancet Diabetes Endocrinol, 2023; 11, 362−74. doi: 10.1016/S2213-8587(23)00060-8 |
| [93] | Pittas AG, Jorde R, Kawahara T, et al. Vitamin D supplementation for prevention of type 2 diabetes mellitus: to D or not to D? J Clin Endocrinol Metab, 2020; 105, 3721-33. |
| [94] | Sherwani SI, Khan HA, Ekhzaimy A, et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights, 2016; 11, 95−104. |
| [95] | Giustina A, Bilezikian JP, Adler RA, et al. Consensus statement on vitamin D status assessment and supplementation: whys, whens, and hows. Endocr Rev, 2024; 45, 625−54. doi: 10.1210/endrev/bnae009 |
| [96] | Dowd P, Ham SW, Naganathan S, et al. The mechanism of action of vitamin K. Annu Rev Nutr, 1995; 15, 419−40. doi: 10.1146/annurev.nu.15.070195.002223 |
| [97] | Qu BY, Yan SM, Ao YR, et al. The relationship between vitamin K and T2DM: a systematic review and meta-analysis. Food Funct, 2023; 14, 8951−63. doi: 10.1039/D3FO02943C |
| [98] | Ma RX, Liu C, Zhang L, et al. Selenium, type-2 diabetes, and the possible protective role of vitamin D. Biomed Environ Sci, 2024; 37, 661−5. |
| [99] | Li Y, Chen JP, Duan LL, et al. Effect of vitamin K2 on type 2 diabetes mellitus: a review. Diabetes Res Clin Pract, 2018; 136, 39−51. doi: 10.1016/j.diabres.2017.11.020 |